Table 2.
Correlation of Daple expression with Wnt5a/b, laminin‐γ2, and β‐catenin expression in patients with gastric cancer
| Total | Daple positive | P‐value | |
|---|---|---|---|
| n (%) | n (%) | ||
| Wnt5a/b positivity | |||
| All cases | |||
| Wnt5a/b positive | 75 (57.7) | 66 (88.0) | <0.001 |
| Wnt5a/b negative | 55 (42.3) | 19 (34.5) | |
| Diffuse‐scattered type | |||
| Wnt5a/b positive | 20 (71.4) | 19 (95.0) | <0.001 |
| Wnt5a/b negative | 8 (28.6) | 2 (25.0) | |
| Other type | |||
| Wnt5a/b positive | 55 (53.9) | 47 (85.5) | <0.001 |
| Wnt5a/b negative | 47 (46.1) | 17 (36.2) | |
| Laminin‐γ2 cytoplasmic positivity | |||
| All cases | |||
| Cytoplasmic positive | 56 (43.1) | 42 (75.0) | 0.06 |
| Others | 74 (56.9) | 43 (58.1) | |
| Diffuse‐scattered type | |||
| Cytoplasmic positive | 17 (60.7) | 16 (94.1) | <0.01 |
| Others | 11 (39.3) | 5 (45.5) | |
| Other type | |||
| Cytoplasmic positive | 39 (38.2) | 26 (66.7) | 0.54 |
| Others | 63 (61.8) | 38 (60.3) | |
| β‐catenin activity | |||
| Nuclear/cytoplasm | 65 (50.0) | 29 (44.6) | 0.32 |
| Others | 65 (50.0) | 11 (16.9) | |